PRPH - ProPhase Labs, Inc.

0.2711
0.031   11.472%

Share volume: 24,822,095
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$0.24
0.03
0.13%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 0%
Dept financing 13%
Liquidity 71%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-21.65%
1 Month
-28.77%
3 Months
-53.97%
6 Months
-88.31%
1 Year
-95.89%
2 Year
-96.81%
Key data
Stock price
$0.27
P/E Ratio 
0.00
DAY RANGE
$0.22 - $0.48
EPS 
-$1.49
52 WEEK RANGE
$0.22 - $7.48
52 WEEK CHANGE
-$95.56
MARKET CAP 
46.170 M
YIELD 
N/A
SHARES OUTSTANDING 
19.079 M
DIVIDEND
$0.30
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
-1.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,370,592
AVERAGE 30 VOLUME 
$2,986,418
Company detail
CEO: Ted W. Karkus
Region: US
Website: prophaselabs.com
Employees: 130
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; Triple Edge XL, an energy and stamina booster. The company was formerly known as The Quigley Corporation.

Recent news
loading